Evidence map›Paper›PMID 39827100›Full record

ArticleRespiratory research2025

Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.

Angélica Domínguez-de-Barros, Gloria Pérez-Rubio, Ingrid Fricke-Galindo, Alejandra Ramírez-Venegas, Malena Gajate-Arenas, Rafael Hernández-Zenteno, Salvador García-Carmona, Robinson Robles-Hernández, María E Ramírez-Díaz, Filiberto Cruz-Vicente and 4 more

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Angélica Domínguez-de-Barros *Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
Gloria Pérez-Rubio *HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas (INER), Ciudad de México, México.
Ingrid Fricke-GalindoHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas (INER), Ciudad de México, México.
Alejandra Ramírez-VenegasDepartamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas (INER), Ciudad de México, México.
Malena Gajate-ArenasInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
Rafael Hernández-ZentenoDepartamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas (INER), Ciudad de México, México.
Salvador García-CarmonaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas (INER), Ciudad de México, México.
Robinson Robles-HernándezDepartamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas (INER), Ciudad de México, México.
María E Ramírez-DíazCoordinación de Vigilancia Epidemiológica, Tlacolula de Matamoros Oaxaca, Servicios de Salud de Oaxaca, Jurisdicción 06 Sierra, Oaxaca, México.
Filiberto Cruz-VicenteDepartamento de Medicina Interna, Hospital Civil Aurelio Valdivieso, Servicios de Salud de Oaxaca, Oaxaca, México.
María L Martínez-GómezHospital Regional de Alta Especialidad de Oaxaca, Oaxaca, México.
Jacob Lorenzo-MoralesInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
Ramcés Falfán-ValenciaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas (INER), Ciudad de México, México. fanv@iner.gob.mx.
Elizabeth Córdoba-LanúsInstituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias (IUETSPC), Universidad de La Laguna, San Cristóbal de La Laguna, Tenerife, Spain. acordoba@ull.edu.es.

Funding

Agencia Canaria de Investigación, Innovación y Sociedad de la Información ACIISI 2024Cabildo Insular de Tenerife 2023-2028, PI-CC20232222, Cabildo.23Consorcio Centro de Investigación Biomédica (CIBER) de Enfermedades Infecciosas (CIBERINFEC) , Instituto de Salud Carlos III, 28006 Madrid, Spain (CB21/13/00100)
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is characterized by progressive airflow obstruction and destruction of lung tissue, primarily attributed to tobacco smoking. However, other factors like biomass-burning smoke (BS) exposure are also implicated. COPD has been described as an accelerated aging disease, and telomere length is a biomarker of aging.

methodsThis study examined telomere length in 189 Mexican individuals, from which 93 developed COPD secondary to BS exposure (BE-COPD); the rest of the participants were exposed to BS but did not develop the disease. Lung function parameters were measured by spirometry, and relative telomere length (rTL) from peripheral blood DNA was determined using multiplex qPCR.

resultsResults showed rTL to inversely correlate with age (R

conclusionsThis is the first study to document that individuals with COPD secondary to biomass smoke exposure present shorter telomeres than BS-exposed subjects who did not develop the disease.

Indexed as

BiomassEnvironmental ExposurePulmonary Disease, Chronic ObstructiveSmokeTelomereTelomere HomeostasisTelomere ShorteningAdultAgedFemaleHumansMaleMexicoMiddle AgedSpirometrySmokeBiomass smokeCOPDPulmonary functionTelomere length

Identifiers

PMID39827100
PMCPMC11742994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.